RxDoctor Payments Data

Federico Padua, MD

Family Medicine · San Antonio, TXNPI 1902803687

Payments from drug & device makers

$1,090in general payments, 2019–2025

Across 67 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$441
  • Avanir Pharmaceuticals, Inc.$244
  • GSK$198
  • Sumitomo Pharma America, Inc.$89
  • Bard Peripheral Vascular, Inc.$55
  • AbbVie$39
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$1,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,090 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$9,844
Medicare patients
31
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate50$170,894
JanuviaSitagliptin Phosphate96$60,499
GemtesaVibegron101$54,003
FarxigaDapagliflozin Propanediol70$44,265
AptiomEslicarbazepine Acetate20$34,375
Trelegy ElliptaFluticasone/Umeclidin/Vilanter47$28,620
VraylarCariprazine Hcl15$21,584
Trokendi XrTopiramate13$11,692
TrulicityDulaglutide13$11,609
MounjaroTirzepatide12$11,596
JentaduetoLinagliptin/Metformin Hcl20$10,621
LinzessLinaclotide19$10,267
TradjentaLinagliptin19$9,994
MyrbetriqMirabegron14$6,383
Paliperidone ErPaliperidone26$4,630

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$89$54,003101 claims
Sunovion Pharmaceuticals Inc.Aptiom$441$34,37520 claims
AbbVieVraylar, Linzess$39$31,85134 claims
GSKTrelegy Ellipta$198$28,62047 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →